Budget Impact Of The Introduction Of New Oral Anticoagulants (Noac) For No Valve Atrial Fibrillation (Nvaf) In Extremadura

Value Health. 2014 Nov;17(7):A480. doi: 10.1016/j.jval.2014.08.1390. Epub 2014 Oct 26.

Authors

Parejo Hernández E D P¹, P Gemio Zumalave², M Alvárez Fernández¹, L M Montaño Pérez¹, J L Sánchez Chorro², A Hidalgo³

Affiliations

¹ Servicio Extremeño de Salud, Mérida, Spain.
² Extremadura Health System, Mérida, Spain.
³ Instituto Max Weber, Majadahonda, Spain.

PMID: 27201401
DOI: 10.1016/j.jval.2014.08.1390

No abstract available